You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase I/Ib

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

Not yet recruiting
  • Synovial Sarcoma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Cancer Trial in L'Hospitalet de Llobregat (MBF-362)

Recruiting
  • Cancer
  • L'Hospitalet de Llobregat, Barcelona, Spain
    Instituto Catalan de Oncología
Jul 7, 2023

Prostate Cancer Trial in Mineola, New York (Two-Fraction Stereotactic Body Radiation Therapy (SBRT))

Not yet recruiting
  • Prostate Cancer
  • Two-Fraction Stereotactic Body Radiation Therapy (SBRT)
  • Mineola, New York
  • +1 more
May 9, 2023

Cancer Trial in Barcelona (PBF-999)

Completed
  • Cancer
  • Barcelona, Spain
    Vall d'Hebron institute of oncology (VHIO)
Jan 24, 2023

Advanced Solid Tumor Trial in San Antonio, Anderlecht, Madrid (PM54)

Recruiting
  • Advanced Solid Tumor
  • San Antonio, Texas
  • +2 more
Apr 21, 2023

Glioblastoma, Recurrent Glioblastoma Trial in San Francisco (RMC-5552)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • San Francisco, California
    University of California, San Francisco
Nov 28, 2022

Recurrent High Grade Uterine Cancer Trial in United States (Paclitaxel, Batiraxcept)

Not yet recruiting
  • Recurrent High Grade Uterine Cancer
  • San Francisco, California
  • +3 more
Apr 11, 2023

Lung Cancer Metastatic, EGFR Gene Mutation Trial in San Francisco (Osimertinib, Alisertib)

Recruiting
  • Lung Cancer Metastatic
  • EGFR Gene Mutation
  • San Francisco, California
    University of California, San Francisco
Aug 10, 2022

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (TGR-1202, Ibrutinib)

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Mantle Cell Lymphoma
  • Monterey, California
  • +4 more
Aug 29, 2022

Rheumatoid Arthritis Trial (VC005 tablets, VC005 Tablets Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • VC005 tablets
  • VC005 Tablets Placebo
  • (no location specified)
May 24, 2023

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • +6 more
  • NZV930
  • +2 more
  • Tampa, Florida
  • +9 more
Nov 2, 2022

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Amsterdam (RMC-4630, LY3214996)

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • (no location specified)
Mar 9, 2022

Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
Dec 14, 2022

Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer Trial in San Francisco (Capmatinib, Trametinib)

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer
  • San Francisco, California
    University of California San Francisco
Aug 15, 2022

Advanced Malignancies Trial in Worldwide (MBG453, PDR001, Decitabine)

Terminated
  • Advanced Malignancies
  • Baltimore, Maryland
  • +13 more
Sep 20, 2022

Solid Tumor, Adult Trial in Belgium, United Kingdom, United States (EOS100850, Pembrolizumab, Chemotherapy)

Recruiting
  • Solid Tumor, Adult
  • Hackensack, New Jersey
  • +4 more
Jun 27, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Aurora (sEphB4-HSA with chemo, Cetuximab, Radiation Therapy)

Completed
  • Squamous Cell Carcinoma of Head and Neck
  • sEphB4-HSA with chemotherapy
  • +2 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 9, 2022

Inhibition of Autophagy Synergizes Anti-tumor Effect Trial in Guangzhou (100mg bid dose of hydroxychloroquine combined with

Recruiting
  • Inhibition of Autophagy Synergizes Anti-tumor Effect
  • 100mg bid dose of hydroxychloroquine combined with three predefined dose groups of palbociclib
  • RP2D dose of 100mg bid of hydroxychloroquine combined with palbociclib was selected for phase II clinical trial.
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jul 19, 2023

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial (RP7214)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Aug 17, 2022

Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Jacksonville (Modified GCN+TTF treatment)

Recruiting
  • Pancreas Cancer
  • +3 more
  • Modified GCN+TTF treatment
  • Jacksonville, Florida
    Mayo Clinic
Apr 4, 2022

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Trial in Kashiwa (HRO761,

Recruiting
  • MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
  • Kashiwa, Chiba, Japan
    Novartis Investigative Site
May 2, 2023

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

Solid Tumor, Adult, Carcinoma, Ovarian Epithelial, Fallopian Tube Tumors Trial in Houston (BP1001-A (Liposomal Grb2 Antisense

Not yet recruiting
  • Solid Tumor, Adult
  • +5 more
  • BP1001-A (Liposomal Grb2 Antisense Oligonucleotide)
  • BP1001-A (Liposomal Grb2 Antisense Oligonucleotide) with paclitaxel
  • (no location specified)
Jun 7, 2022